Cantata Bio, LLC is enabling researchers and clinicians to solve tomorrows most challenging scientific problems through novel, multiomic approaches that unlock access to genomic and metagenomic information at unprecedented levels. Combining propriety technologies with platform solutions, services, and cutting-edge bioinformatics and software, our unique approaches are solving complex problems, including chromatin topology analysis, small and large structural variant detection, de novo chromosome assembly, haplotype phasing, metagenomics, and microbiome analysis. Customers are positively impacting the fields of epigenetics, developmental biology, cancer research, evolutionary biology, infectious disease, and more. Cantata Bio is a wholly owned subsidiary of Edenroc Sciences, a company formed to cultivate world-class life sciences start-up companies. For more information on Edenroc Sciences, or to learn more about investing in the Edenroc family of companies, visit edenrocsciences.com
